From: The double burden: type 1 diabetes and heart failure—a comprehensive review
Study/Author | Design | Follow-up (years) | Subjects with T1D* | Results |
---|---|---|---|---|
Haji et al. 2023 [17] | Meta-analysis | From 1–12 | 61,885 | RR 3.4 (95% CI, 2.71–4.26) |
Giménez‐Pérez et al. 2023 [179] | Retrospective cohort | 6 | 8412 | The occurrence of HF was 14.4%. In women > 65y HF was the most frequent event (40.5%) |
Chadalavada et al. 2021 [25] | Prospective cohort | 8 | 2626 | RR 2.92 (95% CI, 2.57–3.32) |
Avogaro et al. 2020 [16] | Meta-analysis | 11 ± 3 | 160,096 | IRR 2.9 (95% CI, 2.11–3.99) |
Cai et al. 2020 [20] | Meta-analysis | From 4.5–24 | 166,027 | RR 4.3 (95% CI, 3.54–5.19) |
Larsson et al. 2018 [180] | Prospective cohort | 17 | 247 | RR 2.7 (95% CI, 1.76–4.09) |
McAllister et al. 2018 [18] | Retrospective cohort | 10 | 25,610 | IRR 2.32 (95% CI, 2.20–2.45) |
Rawshani et al. 2018 [26] | Retrospective cohort | 10 | 27,195 | IRR 5.39 (95% CI, 0.46–62.80) |
Rosengren et al. 2015 [19] | Prospective cohort | 7.9 | 33,402 | IRR 4.12 (95% CI, 3.80–4.47) |
Lind et al. 2011 [23] | Prospective cohort | 9 | 20,985 | IRR 3.48 (95% CI, 3.17–3.83) |